F
Felipe C. Albuquerque
Researcher at Barrow Neurological Institute
Publications - 116
Citations - 3718
Felipe C. Albuquerque is an academic researcher from Barrow Neurological Institute. The author has contributed to research in topics: Aneurysm & Embolization. The author has an hindex of 27, co-authored 115 publications receiving 3265 citations. Previous affiliations of Felipe C. Albuquerque include New York Medical College & Murphy Oil.
Papers
More filters
Journal ArticleDOI
Preliminary experience using the Neuroform stent for the treatment of cerebral aneurysms.
TL;DR: The Neuroform stent is a useful device for the treatment of patients with aneurysms that may not otherwise be amenable to endovascular therapy, and in the majority of cases, the stent can be deployed accurately, even within the most tortuous segments of the cerebral vasculature.
Journal ArticleDOI
Usefulness of the Neuroform stent for the treatment of cerebral aneurysms: results at initial (3-6-mo) follow-up.
TL;DR: The Neuroform stent facilitates adequate embolization of complex cerebral aneurysms, which would not otherwise be amenable to endovascular therapy.
Journal ArticleDOI
Definitive reconstruction of circumferential, fusiform intracranial aneurysms with the pipeline embolization device
TL;DR: The PED represents an important advance in the endovascular therapy of cerebral aneurysms, targeting primary parent vessel reconstruction rather than endosaccular occlusion as a means by which to achieve exclusion of the aneurYSm and definitive anatomic reconstruction of the parent artery.
Journal ArticleDOI
Treatment of intracranial aneurysms with the Enterprise stent: a multicenter registry
J Mocco,Kenneth V. Snyder,Felipe C. Albuquerque,Bernard R. Bendok,Boulos Alan S,Jeffrey S Carpenter,David Fiorella,Brian L. Hoh,Jay U. Howington,Brian T. Jankowitz,Kenneth M. Liebman,Ansaar T Rai,Rafael Rodriguez-Mercado,Adnan H. Siddiqui,Erol Veznedaroglu,L. Nelson Hopkins,Elad I. Levy +16 more
TL;DR: Initial results of the largest series to date in using the Enterprise for intracranial aneurysm treatment are reported, indicating the Enterprise is associated with a high rate of successful navigation and low occurrence of inaccurate stent deployment.
Journal ArticleDOI
Curative cerebrovascular reconstruction with the Pipeline embolization device: the emergence of definitive endovascular therapy for intracranial aneurysms
David Fiorella,Pedro Lylyk,István Szikora,Michael Kelly,Felipe C. Albuquerque,Cameron G. McDougall,Peter Kim Nelson +6 more
TL;DR: The Pipeline embolization device (PED; Chestnut Medical) represents a new generation endoluminal implant which is designed to treat aneurysms by reconstructing the diseased parent artery.